Skip to main content
. 2022 Jan 4;85(1):415–429. doi: 10.3233/JAD-210677

Table 1.

Patient demographic and disease characteristics expressed as mean (SD).

Cohort A Cohort B
CN– CN+ Prodromal Mild Moderate Prodromal Mild
(n = 6) (n = 5) (n = 13) (n = 12) (n = 10) (n = 24) (n = 40)
Age 59 (8.22) 68.63 (3.38) 69.81 (6.85) 70.6 (6.14) 70.87 (7.02) 70.71 (7.06) 69.28 (7.47)
Female 3 (50%) 2 (40%) 7 (54%) 8 (67%) 2 (20%) 10 (42%) 17 (43%)
Caucasian descent 6 (100%) 4 (80%) 13 100%) 11 (92%) 9 (90%) 23 (96%) 33 (83%)
MMSE 29.33 (0.82) 29.00 (0.71) 28.31 (1.18) 26.58 (2.47) 17.60 (2.76) 25.83 (2.70) 23.03 (2.48)
CDRSB 0.00 (0.00) 0.10 (0.22) 1.58 (0.91) 3.18 (1.27) 6.22 (1.72) 2.56 (1.15) 4.72 (1.85)
ADAS13 12.34 (4.72) 8.00 (4.75) 15.31 (6.11) 19.24 (6.87) 39.78 (7.29) 22.53 (7.39) 29.57 (6.84)
RBANS-Total 98.50 (3.54) 91.8 (11.56) 85.23 (9.28) 77 (14.55) 60.5 (12.12) 76.13 (13.50) 61.24 (11.83)
[18F]GTP1-PET Temp ROI SUVR 1.02 (0.05) 1.26 (0.05) 1.36 (0.19) 1.5 (0.26) 1.67 (0.32) 1.42 (0.34) 1.52 (0.37)
[18F]GTP1-PET WCG SUVR 1.00 (0.05) 1.17 (0.05) 1.18 (0.10) 1.34 (0.27) 1.45 (0.41) 1.2 (0.21) 1.31 (0.26)
[18F]GTP1-PET Braak12 SUVR 1.00 (0.05) 1.27 (0.04) 1.36 (0.17) 1.44 (0.14) 1.48 (0.26) 1.39 (0.22) 1.41 (0.22)
[18F]GTP1-PET Braak34 SUVR 1.00 (0.05) 1.2 (0.05) 1.27 (0.16) 1.44 (0.30) 1.55 (0.35) 1.35 (0.29) 1.46 (0.34)
[18F]GTP1-PET Braak56 SUVR 1.00 (0.06) 1.15 (0.06) 1.13 (0.09) 1.29 (0.26) 1.4 (0.46) 1.14 (0.19) 1.25 (0.25)
Amyloid centiloid –3.47 (8.98) 38.18 (17.53) 79.58 (38.31) 82.71 (32.89) 90.63 (24.61) 70.25 (41.03) 63.10 (35.41)
Elecsys pTau181 (pg/ml) 18.07 (6.52) 22.92 (8.78) 32.8 (18.24) 32.7 (15.11) 36.73 (15.54) 34.74 (21.2) 36.22 (23.75)
Elecsys tTau (pg/ml) 217.02 261.54 317.28 326.48 359.21 331.33 354.1
(77.36) (82.36) (140.77) (118.16) (117.92) (168.76) (199.17)
Elecsys pTau181 (pT181/tTau) 0.083 (0.005) 0.086 (0.008) 0.099 (0.011) 0.098 (0.01) 0.1 (0.011) 0.1 (0.014) 0.098 (0.014)
pT111 (ptau/utau) 0.039 (0.015) 0.065 (0.028) 0.119 (0.044) 0.111 (0.034) 0.137 (0.020) 0.087 (0.035) 0.09 (0.035)
pT153 (ptau/utau) 0.002 (0.000) 0.003 (0.002) 0.009 (0.003) 0.009 (0.004) 0.009 (0.004) 0.007 (0.003) 0.007 (0.003)
pT175 (ptau/utau) 0.003 (0.001) 0.003 (0.001) 0.003 (0.001) 0.003 (0.000) 0.002 (0.001) 0.003 (0.001) 0.003 (0.001)
pT181 (ptau/utau) 0.237 (0.025) 0.300 (0.027) 0.347 (0.059) 0.308 (0.047) 0.28 (0.048) 0.329 (0.058) 0.317 (0.061)
pS199 (ptau/utau) 0.003 (0.001) 0.003 (0.001) 0.004 (0.001) 0.004 (0.002) 0.004 (0.001) 0.005 (0.002) 0.005 (0.001)
pS202 (ptau/utau) 0.039 (0.005) 0.045 (0.016) 0.039 (0.008) 0.039 (0.011) 0.034 (0.005) 0. (0.011) 0.037 (0.013)
pT205 (ptau/utau) 0.004 (0.001) 0.005 (0.002) 0.006 (0.002) 0.008 (0.002) 0.007 (0.001) 0.007 (0.002) 0.007 (0.002)
pS208 (ptau/utau) 0.000 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0) 0.001 (0)
pS214 (ptau/utau) 0.000 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0.000) 0.001 (0) 0.001 (0)
pT217 (ptau/utau) 0.015 (0.003) 0.026 (0.011) 0.061 (0.019) 0.063 (0.020) 0.068 (0.017) 0.053 (0.026) 0.059 (0.025)
pT231 (ptau/utau) 0.050 (0.013) 0.081 (0.046) 0.203 (0.069) 0.147 (0.061) 0.151 (0.051) 0.146 (0.065) 0.157 (0.055)

AD, Alzheimer’s disease; CN, cognitively normal; MMSE; Mini-Mental State Examination; CDRSB; Clinical Dementia Rating Sum of Boxes; ADAS13, Alzheimer’s Disease Assessment Scale; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status; PET, positron emission tomography; ROI, region of interest; SUVR, standardized uptake value ratio. Elecsys pTau181 (pTau181/tTau): ratio of Elecsys pTau181/tTau; LC/MS measures pT/SXXX (ptau/utau): ratio phosphorylated peptide/unphosphorylated peptide.